BEGIN:VCALENDAR PRODID;X-RICAL-TZSOURCE=TZINFO:-//com.denhaven2/NONSGML ri_cal gem//EN CALSCALE:GREGORIAN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:We Need More Cowbell! \; Riders of the annual Tri-State T rek cycle 270 miles from Boston to New York\, making noise and raising m oney to end ALS\, Lou Gehrig&rsquo\;s disease. \; Come to ride\, vol unteer\, or just cheer! \; \; \; \; \;\n \;\n- J uly 22 &ndash\; 24\, 2011\n- 3 days/270 miles\n- www.NeedMoreCowebell.or g\n- NeedMoreCowbell@als.net\n- 617-441-7200\n- Funds raised benefit the ALS Therapy Development Institute \;\n \;\nAbout ALS\nAmyotroph ic lateral sclerosis (ALS\, Lou Gehrig&rsquo\;s disease) is a progressiv e neurodegenerative disease that leads to paralysis\, due to the death o f motor neurons in the spinal cord and brain. There is no known cause\, cure or effective treatment for the disease. About 5\,000 people in the US are diagnosed with ALS each year\; the incidence is similar to Multip le Sclerosis. However\, with no effective treatment and an aggressive an d rapid disease progression\, the average patient survives only 2-5 year s following their diagnosis. There are about 30\,000 US citizens diagnos ed with the disease at any given time. The worldwide population of ALS p atients is estimated at 400\,000.\n \;\nAbout ALS Therapy Developmen t Institute (ALS TDI)\nThe mission of the ALS Therapy Development Instit ute (ALS TDI) is to develop effective therapeutics that slow or stop amy otrophic lateral sclerosis (ALS\, Lou Gehrig&rsquo\;s disease) as soon a s possible for patients today. Focused on meeting this urgent unmet medi cal need\, ALS TDI executes a robust target discovery program\, while si multaneously operating the world&rsquo\;s largest efforts to preclinical ly validate potential therapeutics\; including a pipeline of dozens of s mall molecules\, protein biologics\, gene therapies and cell-based const ructs. The world&rsquo\;s first nonprofit biotech institute\, ALS TDI ha s developed an industrial-scale platform\, employs 30 professional scien tists and evaluates dozens of potential therapeutics each year. Built by and for patients\, the Cambridge\, Massachusetts based research institu te collaborates with leaders in both academia and industry to accelerate ALS therapeutic development\, including Biogen Idec\, UCB\, Aestus Ther apeutics\, MDA and RGK Foundation. For more information\, please visit u s online at www.als.net.\n \; URL:http://brynmawr.patch.com/events/tri-state-trek-bike-ride SUMMARY:Tri-State Trek Bike Ride LOCATION:320 Washington St\, Newton\, MA 02458: 320 Washington St\, Newto n\, MA END:VEVENT END:VCALENDAR